David Hicks, M.D.
Turner Scientific has named David Hicks, M.D. as Chief Executive Officer. Dr. Hicks, formerly Turner Scientific’s business development manager for contract research, will continue to oversee marketing of the company’s research operations. He will also assume responsibility for development of the company’s noise and vibration monitoring services, corporate strategy, human resources, and financial operations.
“We are very excited to promote David to the role of CEO,” said Turner Scientific’s Chief Scientific Officer and founder, Jeremy Turner, PhD. “This is a very promising time for Turner Scientific, as we have also hired two scientists to complement our research staff, and are planning in imminent move to a much larger research facility. David’s leadership, and his understanding of the consequences of hearing loss and tinnitus, make him an excellent choice to guide this continued growth.”
With experience in both clinical hearing disorders and nonclinical auditory science, Dr. Hicks is excited to bridge these disciplines while collaborating with biotechnology companies, pharmaceutical companies, and academic labs. “Dr. Turner has dedicated his career to studying the ears, and has assembled a team of auditory researchers that is unmatched by any other contract research organization,” he says. “It is a privilege to lead this team. This is a period of rapid innovation for hearing treatments, and I greatly enjoy being a part of this growth.”
Prior to Turner Scientific, Dr. Hicks served as Director of Clinical and Business Operations at Fortuna Fix, and Vice President of Fleetridge Pacific, a healthcare mergers and acquisitions advisory firm. As a medical doctor, he received training in ear-related disorders during his residency in otolaryngology.